By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.
Xarelto (Rivaroxaban) is a blood thinner commonly prescribed to prevent blood clots that occur after surgery and to lower the risk of stroke in patients with atrial fibrillation. The FDA initially approved Xarelto in July 2011 as a treatment to reduce the risk of blood clots, especially for those patients undergoing hip- or knee-replacement surgery, but they later expanded its approved uses. When Xarelto was introduced in 2011, it had no antidote and some doctors struggled to stop bleeding in patients who had injuries or needed emergency surgery.
In 2013 the FDA wrote the manufacturers, accusing them of making false and misleading claims and minimizing the risks of Xarelto. Later that year, the number of reported cases of medical problems associated with the drug skyrocketed. Despite this, the manufacturers refused to change the written warnings about Xarelto, and continued to downplay its potential side effects.
Certain types of patients are at an increased risk of developing Xarelto side effects, including but not limited to patients already taking other blood thinners (both over-the-counter and prescription), patients with spinal problems, patients with genetic blood disorders, and patients who are or may become pregnant.
Patients can bleed uncontrollably while taking Xarelto and/or shortly after discontinuing the medication.
Xarelto lawsuits are well underway. Over 1,400 people have filed claims and lawyers are investigating many more such claims across the country. The litigants are seeking compensation from drug manufacturers Janssen Pharmaceuticals and Bayer, claiming that taking the drug caused uncontrolled bleeding, pulmonary embolisms, deep vein thrombosis, strokes, heart attacks, and even wrongful death.
All federal Xarelto lawsuits were consolidated in the Eastern District of Louisiana in December 2014 under the Honorable Eldon E. Fallon.
If you or a loved one have experienced a serious or fatal bleeding event while taking the drug Xarelto, please contact the experienced Drug Litigation Attorneys at Kirkendall Dwyer immediately to discuss the specifics of your case and preserve your legal rights.